Gene Delivery and Gene Editing (Focus Group - GDGE)
Lipid nanoparticles (LNPs) are the leading non-viral platform for delivering large RNA payloads, but organ-specific delivery remains a major challenge. We developed AiLNP, an AI-driven discovery platform, to rationally design first-in-class and best-in-class LNPs with targeted delivery to specific organs, accelerating RNA therapeutic development.
Andong Liu, Ph.D.
Vice President and Head of Technology
METiS Pharmaceuticals, China (People's Republic)